Sai Life Sciences IPO allotment on December 16: Steps to check status on NSE, BSE, Kfin Tech

Sai Life Sciences Limited IPO share allotment status is set to be finalised on December 16 after the successful subscription of the public offer.

The initial public offering (IPO) of the TPG Capital-backed contract research, development, and manufacturing organisation (CRDMO) company was open for subscription from December 11 to December 13. The company aimed to raise ₹3,042.62 crore via IPO.

The mainboard issue garnered strong interest from investors, getting booked over 10 times on the last day of bidding. The IPO received bids worth ₹21,880.92 crore for more than 39.85 crore shares against 3.88 crore shares on offer.

The Qualified Institutional Buyers (QIBs) led the demand by submitting bids for more than 33.01 crore shares against 1.06 crore shares on offer. The QIBs category was booked nearly 31 times.

The Non-Institutional Investors (NIIs) placed bids for over 4.15 crore shares against 84.47 lakh shares set aside for the category. The NIIs booked their segment 4.92 times.

The retail category of Sai Life Sciences IPO was booked 1.37 times with applications for over 2.69 crore shares against 1.97 crore shares on offer.

After the successful subscription, investors now await the finalisation of share allotment status. Those who bid in the IPO can check the update on allotment status online via the official websites of the NSE, BSE and the IPO registrar, Kfin Technologies Limited.

How to check Sai Life Sciences IPO share allotment on BSE

• Log on to the BSE IPO allotment status page at https://www.bseindia.com/investors/appli_check.aspx
• Choose equity from two options given
• Select Jungle Camps India Ltd from the list of issue names
• Enter PAN details or application number
• Complete Captcha verification
• Submit to check the details

How to check Sai Life Sciences IPO share allotment on Kfin Technologies Limited

• Open registrar's link: https://ris.kfintech.com/ipostatus/
• Select any one of the five server links on the screen
• From IPO names, select 'Sai Life Sciences Ltd.'
• Enter your IPO details
• Click on the 'Submit' button

Shares of Sai Life Sciences Limited are scheduled to be listed on the BSE and NSE on December 18.

Sai Life Sciences raised ₹913 crore from anchor investors, including Fidelity Funds, Abu Dhabi Investment Authority, INQ Holding LLC, Goldman Sachs Funds, SmallCap World Fund Inc, BlackRock, Nippon India Mutual Fund (MF), Kotak Mahindra MF, Axis MF and HDFC MF.

Sai Life Sciences IPO Details

Sai Life Sciences Ltd. Offers end-to-end solutions across the drug discovery and manufacturing value chain for small molecule new chemical entities to global pharmaceutical and biotechnology companies.

Here are the key details about the Sai Life Sciences IPO:

• IPO offer size: ₹3,042.62 crore
• Sai Life Sciences IPO is a mix of a fresh issue of 1.73 crore shares and an offer-for-sale (OFS) of 3.81 crore shares.
• The IPO price band has been fixed at ₹522 to ₹549 per share.
• Minimum lot size for retail investors is 27 shares.
• Minimum investment for retail investors is ₹14,823.
• The company will initiate refunds for non-allottees and transfer shares to the Demat accounts of successful bidders on December 17.
• The IPO listing has been scheduled for December 18. Shares of Sai Life Sciences Ltd will be listed on both the NSE and the BSE.

Sai Life Sciences IPO: Use of proceeds

Sai Life Sciences Ltd. aims to use the net proceeds from the IPO to settle debts. Further, a portion of the money will also be used for general corporate purposes.

Sai Life Sciences IPO: Financials

Sai Life Sciences posted revenue of ₹675.29 crore with a net profit of ₹28.01 crore in H1FY25.

The company's revenue in FY24 stood at ₹1,465.1 crore compared to ₹1,217.1 crore in the previous fiscal. Net profits grew sharply to ₹82.21 crore in FY24 from ₹9.98 crore in FY23.

Sai Life Sciences: Shareholding pre and post issue